Chemo patch for skin cancer shows promise in early trial
Disease control
Terminated
This early-stage study tested a new way to deliver the chemotherapy drug doxorubicin directly into basal cell skin cancers using a dissolving microneedle patch. The goal was to find the safest dose and see if it could completely remove the cancer. The trial included 13 adults wit…
Phase: PHASE1 • Sponsor: SkinJect, Inc. • Aim: Disease control
Last updated May 03, 2026 12:28 UTC